These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20193323)

  • 21. Molecular-targeted therapies: lessons from years of clinical development.
    Rosa DD; Ismael G; Lago LD; Awada A
    Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical mechanisms and methods employed in drug delivery to tumors.
    Besić E
    Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary toxicities of biologics: a review.
    Peerzada MM; Spiro TP; Daw HA
    Anticancer Drugs; 2010 Feb; 21(2):131-9. PubMed ID: 20016372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiotoxicity of antineoplastic drugs].
    Drzewoski J; Kasznicki J
    Acta Haematol Pol; 1992; 23(2):79-86. PubMed ID: 1488864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cells carry the clue for targeted treatment: a new horizon for cytopathology.
    Schmitt FC
    Cytopathology; 2007 Oct; 18(5):275-7. PubMed ID: 17883688
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and NMR characterization of hydroxyurea and mesylglycol glycoconjugates as drug candidates for targeted cancer chemotherapy.
    Sorg BL; Hull WE; Kliem HC; Mier W; Wiessler M
    Carbohydr Res; 2005 Feb; 340(2):181-9. PubMed ID: 15639238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticles for drug delivery in cancer treatment.
    Haley B; Frenkel E
    Urol Oncol; 2008; 26(1):57-64. PubMed ID: 18190833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localized delivery of anti-cancer drugs by electroporation.
    Featherstone C
    Mol Med Today; 1998 Feb; 4(2):47. PubMed ID: 9547785
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia.
    Moutouh-de Parseval LA; Weiss L; DeLap RJ; Knight RD; Zeldis JB
    J Clin Oncol; 2007 Nov; 25(31):5047. PubMed ID: 17971612
    [No Abstract]   [Full Text] [Related]  

  • 30. Multi-anticancer drugs encapsulated in the micelle: a novel chemotherapy to cancer.
    Liu P; Wang B; Weili Qiao JL
    Med Hypotheses; 2008 Sep; 71(3):379-81. PubMed ID: 18556140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle and targeted systems for cancer therapy.
    Brannon-Peppas L; Blanchette JO
    Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted therapies: a nursing perspective.
    Kay P
    Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic deregulation of DNA repair and its potential for therapy.
    Hegi ME; Sciuscio D; Murat A; Levivier M; Stupp R
    Clin Cancer Res; 2009 Aug; 15(16):5026-31. PubMed ID: 19671858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspective.
    Perry WL; Weitzman A
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):199-202, 237-8. PubMed ID: 16166991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interstitial lung disease associated with chemotherapy and molecularly-targeted drug: diagnosis and management].
    Saito Y; Gemma A
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2531-7. PubMed ID: 22189216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The polyamine transport system as a target for anticancer drug development.
    Palmer AJ; Wallace HM
    Amino Acids; 2010 Feb; 38(2):415-22. PubMed ID: 19956998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current status and measures for lung injuries in cancer treatment].
    Kudoh S; Yoshimura A
    Gan To Kagaku Ryoho; 2004 May; 31(5):679-84. PubMed ID: 15170972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interstitial pneumonitis].
    Hirai F; Toyokawa G; Ohba T; Kitajima H; Yamaguchi M; Maruyama R; Hamatake M; Seto T; Sugio K; Ichinose Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1782-4. PubMed ID: 22083185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted therapies in lung cancer: a tribute to advancements in clinical research.
    McGee L
    ONS Connect; 2007; 22(8 Suppl):27-8. PubMed ID: 17824552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.